Technology

Advised on Crown Bioscience Inc’s acquisition of Precos - a leading pre-clinical research and development service provider with a focus on oncology.

Advised a national charity on a critical new IT roll out that involved the replacement of its EPOS (Electronic Point of Sale) systems, financial software and related hosting and other services. This was part of a major overhaul of our client’s retail system and involved giving them flexibility on equipment, payment methods and use of mobile devices, as well as extra flexibility in terms of payments. Our advice involved structuring and negotiation of the deal, and the subsequent contract management, co-ordination of different suppliers and ongoing support – covering the whole process and made sure that a consistent process resulted in an agreement giving our client the flexibility and control that it needed.

Advised a national government body on the extension of an existing large scale complex IT services contract covering multiple IT service groups, such as, Data Centre & Hosting Services, Application Management Services, End User Devices, Networks & Telephony and Print Services. We also advised on certain service groups that will need to be removed from the scope of the extended contract prior to expiry, along with the complex pricing and the savings to be made across the service groupings under the restructured contract.

Advised NHS England on its Futures 111 project, including comprehensive corporate, procurement, health and ancillary advice on the reconfiguration and re-procurement of the underlying telephony systems and call-handling for the NHS 111 advice line. We advised on the procurement of the systems and on the government framework, giving NHS England the comfort of having a reliable ongoing service for non-emergency medical advice with robust service levels and remedies for non-performance.

Advising Rapiscan Systems Limited and its parent, OSI Systems Incon patent infringement proceedings brought by American Science & Engineering and, at the same time, a revocation action at the UK Intellectual Property Office relating to one of Rapiscan’s backscatter x-ray detection patents. We were able to instantly provide them with a dedicated team which understands Rapiscan’s commercial and technical objectives, dealing with a dispute that is valued in excess of £10 million, listed with technical difficulty rating of 4, and with a five day trial listed for March 2016.

Acted for our client in proceedings commenced by an individual in respect of alleged copyright infringement in a board game; we acted quickly to ensure that the case was struck out entirely, on the basis that Claimant’s case was based on the misapprehension that copyright could subsist in a mere idea per se and in particular upon the basis that the Claimant’s claim did not disclose any particular copyright work which our client was alleged to infringe, with resulting costs award to our client.